Larimar Therapeutics Falls After $100M Upsized Share Sale; Stock Pulls Back Premarket
Larimar Therapeutics priced an expanded $100 million follow-on offering late Wednesday, selling 20 million shares at $5 apiece. The move sent the stock lower in premarket trading even after a prior week of strong gains tied to an FDA breakthrough designation for its therapy nomlabofusp. Proceeds will support clinical development and general corpora…